KRTAP20-4: A Potential Drug Target and Biomarker (G100151643)

Target Name: KRTAP20-4

NCBI ID: G100151643

KRTAP20-4

Other Name(s): KAP20.4 | keratin associated protein 20-4 | Keratin associated protein 20-4

KRTAP20-4: A Potential Drug Target and Biomarker

Kallikrein-related peptidases (KRTAPs) are a family of transmembrane proteins that regulate proteolytic enzymes, which are essential for tissue repair and maintenance. KRTAPs have been implicated in various physiological processes, including cell signaling, tissue repair, and inflammation. The KRTAP20-4 gene is one of the member of the KRTAP family that has been well studied, and it is known to be involved in several physiological processes in the body. In this article, we will discuss the potential drug target and biomarker properties of KRTAP20-4, and its potential clinical applications.

The KRTAP20-4 gene is located on chromosome 16p13.2 and encodes a 20-kDa protein that belongs to the KRTAP family. This protein is involved in the regulation of proteolytic enzymes, which are enzymes that break down other proteins. KRTAP20-4 is a potent inhibitor of the proteolytic enzyme trypsin, which is involved in the breakdown of extracellular matrix (ECM) components and is a key step in the process of tissue injury and inflammation.

KRTAP20-4 functions as a negative regulator of trypsin, which means that when trypsin is activated, KRTAP20-4 is recruited to the site of the reaction and inhibits its activity. This mechanism of action makes KRTAP20-4 a potential drug target because it can be used to treat conditions that are characterized by the overuse of trypsin, such as cancer, neurodegenerative diseases, and diseases that involve inflammation.

In addition to its role in regulating trypsin, KRTAP20-4 has also been shown to be involved in several other physiological processes. For example, KRTAP20-4 has been shown to be involved in the regulation of cell signaling, including the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and has been implicated in the development and progression of many diseases, including cancer.

KRTAP20-4 has also been shown to be involved in the regulation of inflammation. It has been shown to play a role in the regulation of the production of pro-inflammatory cytokines, such as TNF-伪 and IL-1尾. These cytokines are involved in the regulation of immune and inflammatory responses, and have been implicated in the development and progression of many diseases, including autoimmune diseases and inflammatory bowel diseases.

KRTAP20-4 has also been shown to be involved in the regulation of cell migration. This process is involved in the movement of cells to new locations in the body, and is essential for the development and progression of many diseases, including cancer.

In conclusion, KRTAP20-4 is a protein that has been well studied for its role in the regulation of proteolytic enzymes, cell signaling, inflammation, and cell migration. Its potential drug target and biomarker properties make it an attractive candidate for further research and development. Further studies are needed to fully understand the role of KRTAP20-4 in the regulation of these processes and to determine its potential clinical applications.

Protein Name: Keratin Associated Protein 20-4

Functions: In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins (By similarity)

The "KRTAP20-4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRTAP20-4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets